← Back to Search

Questionnaire

Socio-Geriatric Support for Aging Individuals (ESOGER Trial)

N/A
Recruiting
Research Sponsored by Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 65 and more
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

ESOGER Trial Summary

This trial will test a questionnaire to help support elderly people who are living alone and have seen their health deteriorate during the COVID-19 pandemic. The hope is that the questionnaire will help to identify the most vulnerable elderly people and provide them with the resources they need.

Who is the study for?
This trial is for elderly people aged 65 or older living at home in the CCSMTL's Jeanne-Mance territory, who are experiencing varying degrees of frail health as indicated by a BGA score of 1/14 or more. It excludes those already in another trial, living outside the specified area, or unable to understand French or English.Check my eligibility
What is being tested?
The study tests the ESOGER questionnaire delivered via a secure digital platform. This tool aims to rapidly assess and address the needs of elderly individuals by identifying their vulnerabilities and directing them to appropriate resources.See study design
What are the potential side effects?
Since this intervention involves recommendations based on questionnaire assessments rather than medical treatments, there are no direct physical side effects. However, participants may experience emotional responses to questions about their health and social situation.

ESOGER Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 65 years old or older.

ESOGER Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Autonomy
COVID-19 symptoms
Participant's Quality of life
+3 more
Secondary outcome measures
Caregiver burden

ESOGER Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group InterventionExperimental Treatment1 Intervention
Experimental: Group 1 The intervention group will take the ESOGER questionnaire at month 0 and month 3 ( beginning and end) and receive recommendations following their needs.
Group II: Group controlActive Control1 Intervention
The participants will only take the ESOGER questionnaire at month 0 and month 3 without recommendations

Find a Location

Who is running the clinical trial?

Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-MontréalLead Sponsor
9 Previous Clinical Trials
3,987 Total Patients Enrolled
3 Trials studying Social Isolation
514 Patients Enrolled for Social Isolation

Media Library

Social Isolation Research Study Groups: Group Intervention, Group control
Social Isolation Clinical Trial 2023: ESOGER Highlights & Side Effects. Trial Name: NCT05062590 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being recruited for this research endeavor?

"Yes, the public listing on clinicaltrials.gov shows that this experiment is presently recruiting patient applicants. Posting initially made on April 4th 2022 and we recently updated it on July 19th 2022. We are accepting 260 individuals from a single clinic to join us in our endeavour."

Answered by AI

Is there still room available in this research program for participants?

"Per details hosted on clinicaltrials.gov, this medical experiment is presently recruiting participants. It was initially advertised on April 4th 2022 and had a most recent update in July 19th 2022."

Answered by AI
~91 spots leftby Jun 2025